Analgesics in Portugal

Analgesics in Portugal

  • September 2016
  • 31 pages
  • Euromonitor International
Report ID: 190155
Consumers’ inclination towards self-medication and increasing incidences of headaches and other pain due to stress brought on by hectic working lifestyles remained two major factors behind the growing sales of analgesics in 2016. These products provide quick and effective pain relief, enabling the consumer to resume their daily routine. A recent study indicated that 30% of Portugal’s adult population suffers from chronic pain, therefore analgesics are considered a must have in household first ai...

Euromonitor International’s Analgesics in Portugal report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

ANALGESICS IN PORTUGAL
Euromonitor International
September 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2011-2016
Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Generis Farmacêutica SA in Consumer Health (portugal)
Strategic Direction
Key Facts
Summary 1 Generis Farmacêutica SA: Key Facts
Summary 2 Generis Farmacêutica SA: Operational Indicators
Competitive Positioning
Summary 3 Generis Farmacêutica SA: Competitive Position 2016
Laboratório Medinfar Produtos Farmacêuticos SA in Consumer Health (portugal)
Strategic Direction
Key Facts
Summary 4 Laboratório Medinfar: Key Facts
Competitive Positioning
Summary 5 Laboratório Medinfar: Competitive Position 2016
Novartis Farma - Produtos Farmaceuticos SA in Consumer Health (portugal)
Strategic Direction
Key Facts
Summary 6 Novartis Farma - Produtos Farmaceuticos SA: Key Facts
Competitive Positioning
Summary 7 Novartis Farma - Produtos Farmaceuticos SA: Competitive Position 2016
Omega Pharma Portuguesa Unipessoal Lda in Consumer Health (portugal)
Strategic Direction
Key Facts
Summary 8 Omega Pharma Portuguesa Unipessoal Lda: Key Facts
Competitive Positioning
Summary 9 Omega Pharma Portuguesa Unipessoal Lda: Competitive Position 2016
Pfizer Sa, Laboratórios in Consumer Health (portugal)
Strategic Direction
Key Facts
Summary 10 Laboratórios Pfizer SA: Key Facts
Competitive Positioning
Summary 11 Laboratórios Pfizer SA: Competitive Position 2016
Executive Summary
Consumer Health Enjoys Positive Value Growth in 2016
Health and Wellness Remains Important in Portugal, Despite Economic Constraints
Fragmentation Characterises the Consumer Health Market in 2016
Chemists/pharmacies Account for the Majority of Sales, Followed by Supermarkets
Consumer Health Is Forecast To Register Positive Growth Between 2016 and 2021
Key Trends and Developments
Consumers Remain Fairly Cautious Despite Many Positive Economic Indicators
Ongoing Trend Towards Self-medication
Consumer Health Sales Driven by the Ageing and Obesity Trends
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 12 Research Sources












Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.

Country=Portugal Industry=OTC ParentIndustry=Pharmaceutical Date=201609 Topic=MarketReport Publisher=EuromonitorInternational Price=1000